Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1Phase 1/2 1

Status

Completed 3Unknown 2Recruiting 1

Sponsor Class

OTHER 101NETWORK 31INDUSTRY 26NIH 18OTHER_GOV 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 6

Conditions

Uterine Cervical Neoplasms 6Esophageal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Nasopharyngeal Carcinoma 5Lung Neoplasms 5Nasopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Breast Neoplasms 3Neoplasms, Germ Cell and Embryonal 2Head and Neck Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Squamous Cell 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Recurrence 1Ovarian Neoplasms 1Oesophagogastric Cancer 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Locally Advanced Cervical Carcinoma 1Locally Advanced Cervical Cancer 1Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer 1Gastro-enteropancreatic neuroendocrine tumor 1Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1Endometrial Neoplasms 1EGFR Positive Non-small Cell Lung Cancer 1

Interventions

Cisplatin 6Radiotherapy 4Hydralazine 3Gemcitabine 3Valproic Acid 2Probiotics 2Paclitaxel 2Drug Therapy 2Brachytherapy 2spartalizumab 1nimotuzumab 1belotecan 1apatinib 1Therapeutics 1Surgical Procedures, Operative 1Standard of Care 1Radiotherapy, Intensity-Modulated 1Radiation Dose Hypofractionation 1Proto-Oncogene Proteins c-raf 1Neoadjuvant Therapy 1Nelfinavir 1Mobile Health Units 1Magnetic Resonance Spectroscopy 1Magnesium 1Injections 1Immune Checkpoint Inhibitors 1Hysteroscopy 1Heart Rate 1Fatty Acids, Omega-3 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER_GOV × Uterine Cervical Neoplasms × Cisplatin × Clear all
NCT03256916 2026-02-24

NELCER

Tata Memorial Hospital

Phase 3 Completed
348 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT05910177 2024-03-06

Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin

Fujian Cancer Hospital

Phase 2 Recruiting
30 enrolled
Gynecologic

Carcinoma, Uterine Cervical Neoplasms

NCT02957266 2016-11-15

CERVIPIB

The National Center of Oncology, Azerbaijan

Phase 3 Unknown
400 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT02095119 2015-04-14

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

National Institute of Cancerología

Phase 1/2 Completed
15 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00122772 2011-10-14

CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy

International Atomic Energy Agency

Phase 3 Completed
601 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00122746 2011-10-13

Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients

International Atomic Energy Agency

Phase 3 Unknown
322 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡